VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IOBT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IOBTIO Biotech, Inc.
$0.01$857214
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIOBTQuarterly Financials

IO Biotech, Inc. (IOBT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

IO Biotech, Inc. (IOBT) quarterly income statement — complete revenue, gross profit & net income history

IOBT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold230K234K227K219K205K214K211K201K194K187K174K190K00000000
COGS % of Revenue--------------------
Gross Profit-230K-234K-227K-219K-205K-214K-211K-201K-194K-187K-174K-190K00000000
Gross Margin %--------------------
Gross Profit Growth %-12.2%-9.35%-7.58%-8.96%-5.67%-14.44%-21.26%-5.79%------------
Operating Expenses19.13M22.94M22.36M26.72M26.3M21.32M19.99M27.98M23.29M21.66M17.75M20.2M15.87M18.16M17.01M21.39M7.04M8.98M3.81M2.54M
OpEx % of Revenue--------------------
Selling, General & Admin5.38M6.28M5.98M5.58M6.12M5.47M5.67M6.21M5.63M5.16M5.85M5.77M5.84M5.93M6.7M4.96M2.91M2.25M965K329K
SG&A % of Revenue--------------------
Research & Development13.74M16.65M16.38M21.15M20.18M15.85M14.31M21.77M17.66M16.5M11.9M14.43M10.02M12.23M10.31M16.44M4.13M6.74M2.85M2.21M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-19.36M-23.17M-22.58M-26.94M-26.5M-21.53M-20.2M-28.18M-23.48M-21.85M-17.92M-20.39M-15.87M-18.16M-17.01M-21.39M-7.04M-8.98M-3.81M-2.54M
Operating Margin %--------------------
Operating Income Growth %26.97%-7.6%-11.82%4.4%-12.86%1.46%-12.68%-38.23%-48.02%-20.32%-5.37%4.7%-125.29%-102.17%-346.11%-742.65%---82.66%-
EBITDA-19.13M-22.94M-22.36M-26.72M-26.3M-21.32M-19.99M-27.98M-23.29M-21.66M-17.75M-20.2M-15.75M-18.15M-16.79M-21.39M-7.04M-8.98M-3.68M-2.54M
EBITDA Margin %--------------------
EBITDA Growth %27.28%-7.58%-11.86%4.5%-12.92%1.6%-12.6%-38.53%-47.91%-19.37%-5.72%5.59%-123.57%-102.07%-356.75%-741.31%----
D&A (Non-Cash Add-back)230K234K227K219K205K214K211K201K194K187K174K190K119K11K220K500-1K1K00
EBIT-9.16M-25.85M-22.27M-30.89M-23.81M-20.31M-19.04M-25.83M-22.12M-20.65M-16.64M-19.08M-15.49M-18.29M-17.02M-21.09M-4.39M-38.29M-3.68M-2.54M
Net Interest Income-631K32K414K722K1.07M1.31M1.62M1.95M1.71M1.2M1.03M780K379K56K-108K-151K-67K-71K-72K-11K
Interest Income255K285K414K722K1.07M1.31M1.62M1.95M1.71M1.2M1.03M780K457K158K15K00000
Interest Expense886K253K000000000078K102K123K151K67K71K72K11K
Other Income/Expense9.31M-2.93M309K-3.94M2.7M1.22M1.16M2.35M1.37M1.21M1.29M1.3M292K-230K-128K154K2.58M-29.38M65K-15K
Pretax Income-10.04M-26.1M-22.27M-30.89M-23.81M-20.31M-19.04M-25.83M-22.12M-20.65M-16.64M-19.08M-15.57M-18.39M-17.14M-21.24M-4.46M-38.36M-3.75M-2.55M
Pretax Margin %--------------------
Income Tax-1.66M118K146K445K209K374K415K353K-439K532K406K987K115K104K66K68K0000
Effective Tax Rate %16.57%-0.45%-0.66%-1.44%-0.88%-1.84%-2.18%-1.37%1.98%-2.58%-2.44%-5.17%-0.74%-0.57%-0.39%-0.32%0%0%0%0%
Net Income-8.38M-26.22M-22.42M-31.33M-24.02M-20.69M-19.46M-26.18M-21.68M-21.18M-17.04M-20.07M-15.69M-18.5M-17.2M-21.31M-4.46M-38.36M-3.75M-2.55M
Net Margin %--------------------
Net Income Growth %65.11%-26.74%-15.23%-19.67%-10.78%2.32%-14.16%-30.45%-38.19%-14.51%0.93%5.81%-251.59%51.78%-359.02%-734.34%---24.93%-
Net Income (Continuing)-8.38M-26.22M-22.42M-31.33M-24.02M-20.69M-19.46M-26.18M-21.68M-21.18M-17.04M-20.07M-15.69M-18.5M-17.2M-21.31M-4.46M-38.36M-3.75M-2.55M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.13-0.40-0.34-0.48-0.36-0.31-0.30-0.40-0.43-0.73-0.59-0.70-0.54-0.64-0.60-0.83-0.17-3.32-0.32-0.22
EPS Growth %63.89%-29.03%-13.33%-20%16.28%57.53%49.15%42.86%20.37%-14.06%1.67%15.66%-217.65%80.72%-87.5%-277.27%--98.38%-
EPS (Basic)-0.13-0.40-0.34-0.48-0.36-0.31-0.30-0.40-0.43-0.73-0.59-0.70-0.54-0.64-0.60-0.83-0.17-3.32-0.32-0.22
Diluted Shares Outstanding66.94M65.88M65.88M65.88M65.88M65.88M65.88M65.88M50.17M28.82M28.82M28.82M28.82M28.82M28.82M25.73M25.73M11.55M11.55M11.55M
Basic Shares Outstanding66.94M65.88M65.88M65.88M65.88M65.88M65.88M65.88M50.17M28.82M28.82M28.82M28.82M28.82M28.82M25.73M25.73M11.55M11.55M11.55M
Dividend Payout Ratio--------------------